LMNR earnings analysis
What we found in LMNR's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted 10-Q does not include the financial statements needed to assess revenue, margins, EPS, balance-sheet trends, or cash flow. The principal disclosed development is the March 23, 2026 suspension of regular dividends to fund strategic investments, alongside $244,000 of preferred dividend arrearages. Controls were deemed effective as of July 31, 2026, and management reported no material changes to previously disclosed risk factors.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Controls remained effective
- Management concluded that disclosure controls and procedures were effective as of July 31, 2026. The filing also reports no significant changes in internal controls during the quarter ended July 31, 2026.
- Capital prioritized over dividends
- The Board paused regular cash dividends on March 23, 2026 to support strategic investments, including avocado conversion and housing development. Management expects to resume dividends when deemed prudent, but no date is specified.
- Preferred dividend arrearages disclosed
- The company reported 13,311 Series B and 9,300 Series B-2 preferred shares outstanding as of the filing date, with dividend arrearages of $58,000 and $186,000, respectively.
- No share repurchases completed
- No shares were repurchased under the $30.0 million share repurchase authorization as of July 31, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Suspended dividends and arrearages
- Dividend payments were paused on March 23, 2026, and preferred dividend arrearages totaled $244,000 as of the filing date ($58,000 for Series B plus $186,000 for Series B-2).
- Preferred obligations remain outstanding
- The company has 13,311 Series B and 9,300 Series B-2 preferred shares outstanding, creating ongoing preferred dividend obligations despite the pause in payments.
- No new risk-factor changes
- The filing states there were no material changes to the risk factors in the October 31, 2025 Form 10-K, filed December 23, 2025; therefore, no new risk-factor changes were identified in this 10-Q.
What they said about what is next.
The extracted 10-Q does not provide quantitative revenue or EPS guidance. Management states it expects to resume dividends aligned with historical practice when the Board deems it prudent, but no timing or amount is provided.
The filing reads worse than the one before it.
What came before.
- 10-Q · June 9, 2026
- Limoneira Company reported a significant decline in Q2 FY2026, with total revenues of $23.9 million, falling short of estimates, while net loss surged to $21.4 million. This represents a 32% decrease in revenue compared…
- 10-Q · March 12, 2026
- Limoneira reported Q1 FY2026 revenue of $18.205M and a net loss of $9.313M (net loss per diluted share $0.53), driven by a sharp decline in agribusiness sales after the transition of lemon marketing to Sunkist.…
- 10-K · December 23, 2025
- Limoneira’s 2025 10-K highlights strategic portfolio actions (Chile property sale for $15.0M, a Commercial Packinghouse License with Sunkist effective Nov. 1, 2025, and a $30.0M share repurchase authorization) while the…
- 10-K · December 23, 2024
- Limoneira Company (LMNR) reported a mixed performance in its fiscal year 2024, highlighted by a strategic review aimed at maximizing stockholder value amidst ongoing challenges in the lemon market. Although total…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing LMNR makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever